Moreover, this therapy could work adequately in HPV-related cervical cancer, where the remaining p53 that is not degraded by E6 could be sufficient to induce mitochondrial apoptosis through the newly transplanted healthy mitochondria. Here, TP53 is linked to cervical carcinoma.